首页> 美国卫生研究院文献>Quantitative Imaging in Medicine and Surgery >Characterization of microvessels and parenchyma in in-line phase contrast imaging CT: healthy liver cirrhosis and hepatocellular carcinoma
【2h】

Characterization of microvessels and parenchyma in in-line phase contrast imaging CT: healthy liver cirrhosis and hepatocellular carcinoma

机译:在线相衬造影CT中微血管和实质的特征:健康的肝肝硬化和肝细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHepatocellular carcinoma (HCC) is a cancer with a poor prognosis, and approximately 80% of HCC cases develop from cirrhosis. Imaging techniques in the clinic seem to be insufficient for revealing the microstructures of liver disease. In recent years, phase contrast imaging CT (PCI-CT) has opened new avenues for biomedical applications owing to its unprecedented spatial and contrast resolution. The aim of this study was to present three-dimensional (3D) visualization of human healthy liver, cirrhosis and HCC using a PCI-CT technique called in-line phase contrast imaging CT (ILPCI-CT) and to quantitatively evaluate the variations of these tissues, focusing on the liver parenchyma and microvasculature.
机译:背景肝细胞癌(HCC)是预后较差的癌症,大约80%的HCC病例是由肝硬化引起的。临床中的成像技术似乎不足以揭示肝脏疾病的微观结构。近年来,由于其空前的空间分辨率和对比度分辨率,相衬成像CT(PCI-CT)为生物医学应用开辟了新途径。这项研究的目的是使用称为在线相衬造影CT(ILPCI-CT)的PCI-CT技术,对人体健康的肝,肝硬化和HCC进行三维(3D)可视化,并定量评估这些变化组织,集中在肝实质和微脉管系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号